ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Vipivotide tetraxetan Linker
C33H45N5O9
655.7 g/mol
Pharmaceutical Intermediate

Vipivotide tetraxetan Linker

CAS1703768-74-4
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Vipivotide tetraxetan Linker is a pharmaceutical intermediate used in the manufacturing of PSMA-targeted ligand-linker conjugates. The compound features multiple amide and carboxylic acid functional groups, contributing to its high polarity and flexibility.

PSMA-targeted ligand-linker conjugate intermediatePharmaceutical manufacturing intermediate

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Vipivotide tetraxetan Linker?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.76

Vipivotide tetraxetan

CAS1702967-37-0

pharmaceutical raw material

ReferenceSame Category

6-(1-Methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one

CAS1703794-32-4

pharmaceutical intermediate

ReferenceSame Category

4-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine

CAS1703794-33-5

pharmaceutical intermediate

ReferenceSame Category

Tert-butyl 4-(5-(4-fluorobenzoyl)pyrimidin-2-yl)piperazine-1-carboxylate

CAS1703794-73-3

pharmaceutical intermediate

ReferenceSame Category

(4-fluorophenyl)(2-(piperazin-1-yl)pyrimidin-5-yl)methanone hydrochloride

CAS1703795-52-1

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-[[(1S)-5-[[(2S)-2-[[4-(aminomethyl)cyclohexanecarbonyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-1-carboxypentyl]carbamoylamino]pentanedioic acid

InChIKey

JHWCOTSIOATVKA-MOTXCXSHSA-N

SMILES

C1CC(CCC1CN)C(=O)N[C@@H](CC2=CC3=CC=CC=C3C=C2)C(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O

Synonyms (6)
  • PSMA-617 Linker
  • Vipivotide tetraxetan Linker

Sourcing Vipivotide tetraxetan Linker?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→